Freedom Day Solutions’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Freedom Day Solutions's NVO Position: Q3 2025 in Review
Freedom Day Solutions sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 22,511 shares — an estimated $1.55M sold.
Freedom Day Solutions first reported a position in NVO in Q2 2022 and held it in 13 quarters. The position peaked at $3.47M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Freedom Day Solutions reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- Freedom Day Solutions sold 22,511 Novo Nordisk shares in Q3 2025, an estimated $1.55M.
- Freedom Day Solutions first reported a position in Novo Nordisk in Q2 2022 and held it in 13 quarters.
- Freedom Day Solutions's Novo Nordisk position peaked at $3.47M in Q2 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Freedom Day Solutions's 13F filing for Q3 2025, filed 24 Oct 2025.